NCT00154492已完成2 期
Effectiveness and Safety of Use of NovoSeven® in the Treatment of Active Variceal Bleeding in Patients With Advanced Cirrhosis
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 265
- 试验地点
- 45
- 主要终点
- Treatment failure
研究概览
简要总结
This trial is conducted in Asia and Europe. The trial is planned to investigate the effectiveness and safety of NovoSeven® in patients with advanced cirrhosis and active variceal bleeding.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 79 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Variceal bleeding
排除标准
- 未提供
结局指标
主要结局
Treatment failure
时间窗: Within 5 days after first trial product administration
次要结局
- Mortality
- Rebleeding
- Control of acute bleeding
研究者
研究点 (45)
Loading locations...
相似试验
已完成
不适用
Clinical trials for efficacy and safety for a novel device intermediating traditional needle electrodes to BIS-VISTA system for frontal neurosurgical procedureGeneral Anesthesia cases management with processed EEG monitoringJPRN-UMIN000031217Kurume University20
招募中
2 期
Clinical trial to verify safety and efficacy of Stemirac that does not meet in-process control specifications and shipping specifications for acute traumatic spinal cord injury patients.JPRN-jRCT2013210056Tomii Ryo10
进行中（未招募）
不适用
Ensayo clínico para evaluar la eficacia de los suplementos de progesterona natural en la prevención del parto pretérmino gemelarEUCTR2004-004136-31-ESaboratorios Effik, S.A.
进行中（未招募）
2 期
An international randomised clinical trial of therapeutic interventions with the potential to improve outcome in adults with acute myeloid leukaemia and high-risk myelodysplasia undergoing allogeneic stem cell transplantatioAcute myeloid leukaemia, myelodysplastic syndromesCancerISRCTN12434060niversity of Birmingham333
招募中
不适用
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung CancerNon Small Cell Lung CancerEsophageal CancerNCT03908671Stemirna Therapeutics24